286 related articles for article (PubMed ID: 31588557)
1. Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century.
Yadav S; Karam D; Bin Riaz I; Xie H; Durani U; Duma N; Giridhar KV; Hieken TJ; Boughey JC; Mutter RW; Hawse JR; Jimenez RE; Couch FJ; Leon-Ferre RA; Ruddy KJ
Cancer; 2020 Jan; 126(1):26-36. PubMed ID: 31588557
[TBL] [Abstract][Full Text] [Related]
2. Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
Chen W; Huang Y; Lewis GD; Szeja SS; Hatch SS; Farach A; Miltenburg D; Butler EB; Chang JC; Teh BS
Clin Breast Cancer; 2018 Feb; 18(1):e97-e105. PubMed ID: 28888581
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
[TBL] [Abstract][Full Text] [Related]
4. Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores.
Chen J; Wu X; Christos PJ; Formenti S; Nagar H
Breast Cancer Res; 2018 Apr; 20(1):26. PubMed ID: 29661221
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of biological subtype overrides that of TNM staging in breast cancer: discordance between stage and biology.
Jung HA; Park YH; Kim M; Kim S; Chang WJ; Choi MK; Hong JY; Kim SW; Kil WH; Lee JE; Nam SJ; Ahn JS; Im YH
Tumour Biol; 2015 Feb; 36(2):1073-9. PubMed ID: 25326808
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of partial mastectomy in male breast cancer patients: analysis of SEER, 1983-2009.
Cloyd JM; Hernandez-Boussard T; Wapnir IL
Ann Surg Oncol; 2013 May; 20(5):1545-50. PubMed ID: 23460016
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis.
Gargiulo P; Pensabene M; Milano M; Arpino G; Giuliano M; Forestieri V; Condello C; Lauria R; De Placido S
BMC Cancer; 2016 Jul; 16():375. PubMed ID: 27377827
[TBL] [Abstract][Full Text] [Related]
8. Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016.
Yang Y; Pan L; Shao Z
Breast Cancer Res Treat; 2021 Dec; 190(3):503-515. PubMed ID: 34554371
[TBL] [Abstract][Full Text] [Related]
9. Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study.
Yu P; Tang H; Zou Y; Liu P; Tian W; Zhang K; Xie X; Ye F
Cancer Control; 2020; 27(1):1073274820976667. PubMed ID: 33356518
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of male triple negative breast cancer: A population-based study.
Ghani S; Sochat M; Luo J; Tao Y; Ademuyiwa F
Breast J; 2020 Sep; 26(9):1748-1755. PubMed ID: 32856383
[TBL] [Abstract][Full Text] [Related]
11. Does race predict survival for women with invasive breast cancer?
Walsh SM; Zabor EC; Stempel M; Morrow M; Gemignani ML
Cancer; 2019 Sep; 125(18):3139-3146. PubMed ID: 31206623
[TBL] [Abstract][Full Text] [Related]
12. The use of adjuvant radiation therapy in male breast cancer and its impact on outcomes.
Bakalov V; Jayakrishnan TT; Abel S; Hilton C; Rusia B; Wegner RE
Cancer Treat Res Commun; 2021; 27():100359. PubMed ID: 33812181
[TBL] [Abstract][Full Text] [Related]
13. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
[No Abstract] [Full Text] [Related]
14. Analysis of prognostic factors in male breast cancer: a report of 72 cases from a single institution.
Zhou FF; Xia LP; Wang X; Guo GF; Rong YM; Qiu HJ; Zhang B
Chin J Cancer; 2010 Feb; 29(2):184-8. PubMed ID: 20109348
[TBL] [Abstract][Full Text] [Related]
15. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.
Fields EC; DeWitt P; Fisher CM; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):747-52. PubMed ID: 24138917
[TBL] [Abstract][Full Text] [Related]
16. Male breast cancer in the veterans affairs population: a comparative analysis.
Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Outcomes of Signet Ring Cell Carcinoma of the Breast.
Mehdi M; Kong AL; Frebault J; Huang S; Huang CC; Cortina CS
J Surg Res; 2021 Aug; 264():138-148. PubMed ID: 33823490
[TBL] [Abstract][Full Text] [Related]
18. An overview of triple-negative breast cancer.
Kumar P; Aggarwal R
Arch Gynecol Obstet; 2016 Feb; 293(2):247-69. PubMed ID: 26341644
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
Amirifard N; Sadeghi E
Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]